112 related articles for article (PubMed ID: 28464181)
21. A new model (Alfalfa-Warfarin-GIB) for predicting the risk of major gastrointestinal bleeding in warfarin patients.
Wu S; Lv M; Ma F; Feilong Z; Fang G; Zhang J
Eur J Clin Pharmacol; 2023 Sep; 79(9):1195-1204. PubMed ID: 37392366
[TBL] [Abstract][Full Text] [Related]
22. Association between anticoagulant treatment duration and risk of venous thromboembolism recurrence and bleeding in clinical practice.
Kaatz S; Fu AC; AbuDagga A; LaMori J; Bookhart BK; Damaraju CV; Tan H; Schein J; Nutescu E
Thromb Res; 2014 Oct; 134(4):807-13. PubMed ID: 25127013
[TBL] [Abstract][Full Text] [Related]
23. Impact of INR monitoring, reversal agent use, heparin bridging, and anticoagulant interruption on rebleeding and thromboembolism in acute gastrointestinal bleeding.
Nagata N; Sakurai T; Moriyasu S; Shimbo T; Okubo H; Watanabe K; Yokoi C; Yanase M; Akiyama J; Uemura N
PLoS One; 2017; 12(9):e0183423. PubMed ID: 28863196
[TBL] [Abstract][Full Text] [Related]
24. The Effect of Bleeding Risk and Frailty Status on Anticoagulation Patterns in Octogenarians With Atrial Fibrillation: The FRAIL-AF Study.
Lefebvre MC; St-Onge M; Glazer-Cavanagh M; Bell L; Kha Nguyen JN; Viet-Quoc Nguyen P; Tannenbaum C
Can J Cardiol; 2016 Feb; 32(2):169-76. PubMed ID: 26277091
[TBL] [Abstract][Full Text] [Related]
25. Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia.
Smith A; Young GP; Cole SR; Bampton P
Cancer; 2006 Nov; 107(9):2152-9. PubMed ID: 16998938
[TBL] [Abstract][Full Text] [Related]
26. Venous thromboembolism in cancer patients.
Deng A; Galanis T; Graham MG
Hosp Pract (1995); 2014 Dec; 42(5):24-33. PubMed ID: 25485915
[TBL] [Abstract][Full Text] [Related]
27. Impact of fecal occult blood on obscure gastrointestinal bleeding: observational study.
Kobayashi Y; Watabe H; Yamada A; Suzuki H; Hirata Y; Yamaji Y; Yoshida H; Koike K
World J Gastroenterol; 2015 Jan; 21(1):326-32. PubMed ID: 25574108
[TBL] [Abstract][Full Text] [Related]
28. Uterine bleeding during anticoagulation in women with venous thromboembolism.
Moustafa F; Fernández S; Fernández-Capitán C; Nieto JA; Pedrajas JM; Visoná A; Valero B; Marchena PJ; Braester A; Monreal M;
Thromb Res; 2017 Mar; 151 Suppl 1():S1-S5. PubMed ID: 28262225
[TBL] [Abstract][Full Text] [Related]
29. Acute Severe Gastrointestinal Tract Bleeding Is Associated With an Increased Risk of Thromboembolism and Death.
Nagata N; Sakurai T; Shimbo T; Moriyasu S; Okubo H; Watanabe K; Yokoi C; Yanase M; Akiyama J; Uemura N
Clin Gastroenterol Hepatol; 2017 Dec; 15(12):1882-1889.e1. PubMed ID: 28634133
[TBL] [Abstract][Full Text] [Related]
30. Comparing Length of Stay Between Patients Taking Rivaroxaban and Conventional Anticoagulants for Treatment of Venous Thromboembolism.
Desai A; Desai A; Calixte R; Aparnath M; Hindenburg A; Salzman S; Mathew JP
Lung; 2016 Aug; 194(4):605-11. PubMed ID: 27192990
[TBL] [Abstract][Full Text] [Related]
31. The outcome and role of drugs in patients with unexplained gastrointestinal bleeding.
Hreinsson JP; Bjarnason I; Bjornsson ES
Scand J Gastroenterol; 2015; 50(12):1482-9. PubMed ID: 26087014
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of the SAMe-TT2R2 score to predict the quality of anticoagulation control in a cohort of patients with venous thromboembolism treated with vitamin K antagonists.
Demelo-Rodríguez P; Postigo-Esteban A; García-Fernández-Bravo I; Agud M; Calpena S; Camacho M; Del Toro-Cervera J
Thromb Res; 2016 Nov; 147():58-60. PubMed ID: 27676254
[TBL] [Abstract][Full Text] [Related]
33. The guaiac-based fecal occult blood test in healthy dogs: Evaluation of the effects of diet, and the ability of the test to detect fecal occult blood.
Pierini A; Bartoletti F; Lubas G; Gori E; Marchetti V
Vet Clin Pathol; 2020 Mar; 49(1):71-77. PubMed ID: 32196727
[TBL] [Abstract][Full Text] [Related]
34. Relationship of the SAMe-TT₂R₂ score to poor-quality anticoagulation, stroke, clinically relevant bleeding, and mortality in patients with atrial fibrillation.
Lip GYH; Haguenoer K; Saint-Etienne C; Fauchier L
Chest; 2014 Sep; 146(3):719-726. PubMed ID: 24722973
[TBL] [Abstract][Full Text] [Related]
35. Stroke and bleeding risk co-distribution in real-world patients with atrial fibrillation: the Euro Heart Survey.
Marcucci M; Lip GY; Nieuwlaat R; Pisters R; Crijns HJ; Iorio A
Am J Med; 2014 Oct; 127(10):979-986.e2. PubMed ID: 24838192
[TBL] [Abstract][Full Text] [Related]
36. Significantly higher rates of gastrointestinal bleeding and thromboembolic events with left ventricular assist devices.
Shrode CW; Draper KV; Huang RJ; Kennedy JL; Godsey AC; Morrison CC; Shami VM; Wang AY; Kern JA; Bergin JD; Ailawadi G; Banerjee D; Gerson LB; Sauer BG
Clin Gastroenterol Hepatol; 2014 Sep; 12(9):1461-7. PubMed ID: 24480675
[TBL] [Abstract][Full Text] [Related]
37. Validation of a score for predicting fatal bleeding in patients receiving anticoagulation for venous thromboembolism.
Nieto JA; Solano R; Trapero Iglesias N; Ruiz-Giménez N; Fernández-Capitán C; Valero B; Tiberio G; Bura-Riviere A; Monreal M;
Thromb Res; 2013 Aug; 132(2):175-9. PubMed ID: 23849097
[TBL] [Abstract][Full Text] [Related]
38. Venous thromboembolism in pediatric trauma patients: Ten-year experience and long-term follow-up in a tertiary care center.
Leeper CM; Vissa M; Cooper JD; Malec LM; Gaines BA
Pediatr Blood Cancer; 2017 Aug; 64(8):. PubMed ID: 28067012
[TBL] [Abstract][Full Text] [Related]
39. Duration of anticoagulation for the management of venous thromboembolism in inflammatory bowel disease: a decision analysis.
Nguyen GC; Bernstein CN
Am J Gastroenterol; 2013 Sep; 108(9):1486-95. PubMed ID: 23857476
[TBL] [Abstract][Full Text] [Related]
40. Impact of restarting warfarin therapy in renal disease anticoagulated patients with gastrointestinal hemorrhage.
Khalid F; Qureshi W; Qureshi S; Alirhayim Z; Garikapati K; Patsias I
Ren Fail; 2013 Oct; 35(9):1228-35. PubMed ID: 23902367
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
